Immortalized Rat Tracheal Epithelial Cells (SPOC-1)

Unit

1×10⁶ cells / 1.0 ml

Cell Type

Immortalized Cells

Tissue Type

Airway

Organism

Rat (R. norvegicus)

Donor History

10 – 14 weeks old

Growth Properties

Adherent

,

epithelial

Growth Conditions

PriCoat™ T25 Flasks (G299) or Applied Cell Extracellular Matrix (G422) are recommended for optimal cell culture. PriGrow XII Medium (TM012) +  5 ng/ml EGF (Z100139) + 5 µg/ml Transferrin + 5 µg/ml Insulin (TM053) + 0.1 µg/ml Hydrocortisone (TM066) +  0.1 µg/ml Cholera toxin + 50 mM Ethanolamine + 50 mM Phosphoethanolamine +  0.8 mM CaCl2 + 1.5 mg/ml essentially globulin-free bovine serum albumin (Sigma-Aldrich

,

A4161) +  0.1 µg/ml Bovine pituitary extract + 15mM HEPES (TM058) + 1% Penicillin/Streptomycin Solution (G255)

,

37.0°C

,

5% CO₂.Note: Cells are sensitive to trypsin; Gentle Dissociation Solution (TM080) is recommended for subculture procedures. 

Immortalization Method

Spontaneous immortalization

Full Information

https://www.abmgood.com/immortalized-rat-tracheal-epithelial-cells-spoc-1.html

Katalogové číslo: T0733 Kategorie: ,
Mgr. Otakar Fišer
Máte otázky k tomuto produktu? Kontaktujte našeho specialistu.
Mgr. Otakar Fišer
Produktový manažer - Life Science
Popis

Mucus hypersecretion is a hallmark of inflammatory airway diseases, but few immortalized tracheal cell lines maintain the ability to differentiate into mucus-producing epithelium. Immortalized Rat Tracheal Epithethelial Cells (SPOC-1) were spontaneously derived from secondary cell cultures. Like other tracheal cell lines, SPOC1 exhibits increased proliferative capacity and decreased growth factor requirements relative to primary cells, but is unique in being non-tumorigenic, having a diploid karyotype and possessing the ability to form gland-like epithelial structures in tracheal grafts, which are comprised of mucin-producing mucous goblet cells. These characteristics position SPOC1 as a valuable tool for the study of airway epithelial secretory cell differentiation, function and neoplastic progression, as well as the key molecular events underlying mucous production.

O značce
Applied Biological Materials (abm) je jedním z našich klíčových dodavatelů pro biotechnologický průmysl. Společnost byla založena v roce 2004 a již více než deset let podporuje vědecké objevy v oblasti přírodních věd a vývoje léčiv. Její sídlo se nachází ve Vancouveru v Kanadě. ABM je pro nás neocenitelným partnerem zejména v  oblasti dodávek buněčných kultur, genových a virových vektorů, produktů pro molekulární biologii a PCR, nástrojů pro technologie CRISPR a RNAi, protilátek i základních reagencií pro molekulárně genetické procesy.